Figure 5E shows representative views of a DAPI (blue), cytokeratin (green), and CD45 (red) staining of CTCs derived from the blood of patients with metastatic prostate cancer following isolation using the cmHsp70.1 mAb-based bead approach. This evidence concerns the gene PTPRC and metastatic prostate carcinoma.